Formation Bio
About Formation Bio
The startup has developed a biotech platform that integrates a network of clinical trial sites within existing medical practices, utilizing a mobile cohort of certified research coordinators and advanced software to enhance participant recruitment for research studies. This approach increases access to diverse human subjects for clinical trials, psychological research, and focus groups, addressing the challenge of limited participant availability in traditional drug development processes.
```xml <problem> Traditional drug development faces challenges in efficiently identifying promising drug candidates and navigating the complexities of clinical trials, leading to increased costs and prolonged timelines for bringing new treatments to patients. The existing drug development ecosystem struggles to keep pace with the rapid advancements in drug discovery. </problem> <solution> Formation Bio is a tech-driven pharmaceutical company that acquires and develops clinical-stage drug candidates, leveraging a proprietary AI-native platform to accelerate the drug development process. The company's approach focuses on integrating AI tools across the entire development lifecycle, from identifying and acquiring promising assets to optimizing clinical trial design and execution. By combining a multidisciplinary team of pharma and tech experts with advanced AI systems, Formation Bio aims to drive faster, more precise, and more efficient progress in bringing new treatments to patients. The platform includes AI Drug Hunter for asset selection, AI Drug Developer for R&D strategy, and Automated Clinical Trial capabilities to streamline trial processes. </solution> <features> - AI Drug Hunter: Systematically identifies unmet needs and forecasts the potential of new drug opportunities through therapeutic landscape analysis, ROI modeling, indication mapping, knowledge graphs, and real-time intelligence. - AI Drug Developer: Provides AI-driven guidance across regulatory planning, protocol drafting, and key cross-functional areas, enabling predictive planning, scenario modeling, and AI-generated trial designs. - Automated Clinical Trial: Reduces manual work, accelerates timelines, and improves trial quality through automated study startup, AI-optimized recruitment strategies, and intelligent validation and monitoring. - Proprietary tech-driven platform: Integrates interconnected data and AI tools to redefine how assets are sourced, evaluated, and developed. - Flexible structures and financing pathways: Enables the acquisition and development of clinical-stage drugs from pharma, universities, and biotech. </features> <target_audience> Formation Bio primarily targets pharmaceutical companies, biotech firms, and universities seeking to accelerate the development and commercialization of clinical-stage drug candidates. The company also serves patients seeking access to cutting-edge treatments through participation in clinical trials. </target_audience> ```
What does Formation Bio do?
The startup has developed a biotech platform that integrates a network of clinical trial sites within existing medical practices, utilizing a mobile cohort of certified research coordinators and advanced software to enhance participant recruitment for research studies. This approach increases access to diverse human subjects for clinical trials, psychological research, and focus groups, addressing the challenge of limited participant availability in traditional drug development processes.
When was Formation Bio founded?
Formation Bio was founded in 2013.
How much funding has Formation Bio raised?
Formation Bio has raised 618820000.
- Founded
- 2013
- Funding
- 618820000
- Employees
- 167 employees
- Major Investors
- Andreessen Horowitz